{Reference Type}: Journal Article {Title}: Currently Available Treatment Modalities for Uterine Fibroids. {Author}: Micić J;Macura M;Andjić M;Ivanović K;Dotlić J;Micić DD;Arsenijević V;Stojnić J;Bila J;Babić S;Šljivančanin U;Stanišić DM;Dokić M; {Journal}: Medicina (Kaunas) {Volume}: 60 {Issue}: 6 {Year}: 2024 May 26 {Factor}: 2.948 {DOI}: 10.3390/medicina60060868 {Abstract}: Uterine fibroids (leiomyomas and myomas) are the most common benign gynecological condition in patients presenting with abnormal uterine bleeding, pelvic masses causing pressure or pain, infertility and obstetric complications. Almost a third of women with fibroids need treatment due to symptoms.
OBJECTIVE: In this review we present all currently available treatment modalities for uterine fibroids.
METHODS: An extensive search for the available data regarding surgical, medical and other treatment options for uterine fibroids was conducted.
METHODS: Nowadays, treatment for fibroids is intended to control symptoms while preserving future fertility. The choice of treatment depends on the patient's age and fertility and the number, size and location of the fibroids. Current management strategies mainly involve surgical interventions (hysterectomy and myomectomy hysteroscopy, laparoscopy or laparotomy). Other surgical and non-surgical minimally invasive techniques include interventions performed under radiologic or ultrasound guidance (uterine artery embolization and occlusion, myolysis, magnetic resonance-guided focused ultrasound surgery, radiofrequency ablation of fibroids and endometrial ablation). Medical treatment options for fibroids are still restricted and available medications (progestogens, combined oral contraceptives andgonadotropin-releasing hormone agonists and antagonists) are generally used for short-term treatment of fibroid-induced bleeding. Recently, it was shown that SPRMs could be administered intermittently long-term with good results on bleeding and fibroid size reduction. Novel medical treatments are still under investigation but with promising results.
CONCLUSIONS: Treatment of fibroids must be individualized based on the presence and severity of symptoms and the patient's desire for definitive treatment or fertility preservation.